BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fiati Kenston SS, Song X, Li Z, Zhao J. Mechanistic insight, diagnosis, and treatment of ammonia-induced hepatic encephalopathy. J Gastroenterol Hepatol. 2019;34:31-39. [PMID: 30070387 DOI: 10.1111/jgh.14408] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Luo SH, Chu JG, Huang H, Zhao GR, Yao KC. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy. World J Gastroenterol 2019; 25(9): 1088-1099 [PMID: 30862997 DOI: 10.3748/wjg.v25.i9.1088] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
2 Ribas GS, Lopes FF, Deon M, Vargas CR. Hyperammonemia in Inherited Metabolic Diseases. Cell Mol Neurobiol 2021. [PMID: 34665389 DOI: 10.1007/s10571-021-01156-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yossef S, Clark F, Bubeck SS, Abernethy J, Bayne T, Krishnan K, Young A. An Oral Formulation of the Probiotic, Bacillus subtilis HU58, Was Safe and Well Tolerated in a Pilot Study of Patients with Hepatic Encephalopathy. Evid Based Complement Alternat Med 2020;2020:1463108. [PMID: 32714397 DOI: 10.1155/2020/1463108] [Reference Citation Analysis]
4 Kim TH, Yun SG, Choi J, Goh HG, Lee HA, Yim SY, Choi SJ, Lee YS, Yoon EL, Jung YK, Seo YS, Kim JH, Yim HJ, Yeon JE, Byun KS, Um SH. Differential Impact of Serum 25-Hydroxyvitamin D3 Levels on the Prognosis of Patients with Liver Cirrhosis According to MELD and Child-Pugh Scores. J Korean Med Sci 2020;35:e129. [PMID: 32419396 DOI: 10.3346/jkms.2020.35.e129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Sun M, Zhou R, Wang X, Cheng Y. Influence of Different Antiepileptic Drugs on Blood Ammonia and Homocysteine Levels in Children with Epilepsy. Evid Based Complement Alternat Med 2021;2021:5698765. [PMID: 34646327 DOI: 10.1155/2021/5698765] [Reference Citation Analysis]
6 Zhang C, Ni W, Zhu Y, Lin J, Li H, Zhao Z, Wang K, Huo H, Luo M. Construction and comprehensive analysis of a lncRNA-mRNA interactive network to reveal a potential lncRNA for hepatic encephalopathy development. Hum Cell 2022. [PMID: 35583799 DOI: 10.1007/s13577-022-00714-4] [Reference Citation Analysis]
7 Zhao L, Gao Y, Guo S, Lu X, Yu S, Ge Z, Zhu H, Li Y. Prognosis of Patients with Sepsis and Non-Hepatic Hyperammonemia: A Cohort Study. Med Sci Monit 2020;26:e928573. [PMID: 33373333 DOI: 10.12659/MSM.928573] [Reference Citation Analysis]
8 Hiramine Y, Uto H, Mawatari S, Kanmura S, Imamura Y, Hiwaki T, Saishoji A, Kakihara A, Maenohara S, Tokushige K, Ido A. Efficacy of rifaximin, a poorly absorbed rifamycin antimicrobial agent, for hepatic encephalopathy in Japanese patients. Hepatol Res 2021;51:445-60. [PMID: 33533150 DOI: 10.1111/hepr.13622] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chakravarthy MV, Neutel J, Confer S, Zhao P, Tatsuta N, Rebello S, Comb WC, Hamill M, Tramontin T, Carroll S, Afeyan R, Sanyal AJ. Safety, Tolerability, and Physiological Effects of AXA1665, a Novel Composition of Amino Acids, in Subjects With Child-Pugh A and B Cirrhosis. Clin Transl Gastroenterol 2020;11:e00222. [PMID: 32955200 DOI: 10.14309/ctg.0000000000000222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Chu YY, Wang X, Dai HL. Update on pharmacotherapy of hepatic encephalopathy. Shijie Huaren Xiaohua Zazhi 2021; 29(2): 58-64 [DOI: 10.11569/wcjd.v29.i2.58] [Reference Citation Analysis]
11 Dai R, Sag AA, Martin JG, Befera NT, Pabon-Ramos WM, Suhocki PV, Smith TP, Kim CY, Muir AJ, Ronald J. Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encephalopathy: Replication in an independent patient cohort. Clin Imaging 2021;77:187-92. [PMID: 33940357 DOI: 10.1016/j.clinimag.2021.04.034] [Reference Citation Analysis]
12 Eftekar M. The association between hepatic encephalopathy/minimal hepatic encephalopathy and depressive and anxiety disorders: a systematic review. Australas Psychiatry 2020;28:61-5. [DOI: 10.1177/1039856219875054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Ahmadi S, Faridi S, Tahmasebi S. Calcium-dependent kinases in the brain have site-specific associations with locomotion and rearing impairments in rats with bile duct ligation. Behavioural Brain Research 2019;372:112009. [DOI: 10.1016/j.bbr.2019.112009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]